CAROZZI, VALENTINA ALDA
 Distribuzione geografica
Continente #
NA - Nord America 10.792
EU - Europa 5.907
AS - Asia 3.410
SA - Sud America 33
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 11
Totale 20.206
Nazione #
US - Stati Uniti d'America 10.581
CN - Cina 1.414
IT - Italia 1.120
SG - Singapore 1.115
DE - Germania 1.038
SE - Svezia 897
IE - Irlanda 818
RU - Federazione Russa 620
UA - Ucraina 589
GB - Regno Unito 301
HK - Hong Kong 299
CA - Canada 205
VN - Vietnam 174
FI - Finlandia 155
ID - Indonesia 117
AT - Austria 109
FR - Francia 79
IN - India 74
DK - Danimarca 65
JP - Giappone 64
TR - Turchia 46
KR - Corea 41
BE - Belgio 35
NL - Olanda 30
BR - Brasile 25
MY - Malesia 22
EU - Europa 19
AU - Australia 18
IR - Iran 17
NZ - Nuova Zelanda 14
PL - Polonia 10
ES - Italia 9
EG - Egitto 7
MX - Messico 6
PH - Filippine 6
TW - Taiwan 6
CH - Svizzera 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
HR - Croazia 4
HU - Ungheria 4
CL - Cile 3
NO - Norvegia 3
RO - Romania 3
A1 - Anonimo 2
CO - Colombia 2
IQ - Iraq 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
PK - Pakistan 2
SA - Arabia Saudita 2
SC - Seychelles 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EE - Estonia 1
IL - Israele 1
KG - Kirghizistan 1
LV - Lettonia 1
PE - Perù 1
PT - Portogallo 1
VE - Venezuela 1
Totale 20.206
Città #
Ann Arbor 2.213
Singapore 923
Woodbridge 900
Dublin 792
Chandler 741
Houston 653
Jacksonville 619
Frankfurt am Main 606
Fairfield 534
Dearborn 505
Wilmington 485
Milan 443
Ashburn 422
Santa Clara 336
Hangzhou 332
New York 323
Princeton 304
Hong Kong 279
Seattle 219
Nanjing 199
Cambridge 165
Boardman 144
Shanghai 138
Jakarta 117
Vienna 108
Beijing 105
Lachine 102
Altamura 92
Dong Ket 89
Lawrence 82
Guangzhou 75
Nanchang 72
Shenyang 62
Andover 51
Toronto 45
Helsinki 42
Grafing 37
Jiaxing 35
Ottawa 34
Changsha 33
Fremont 33
Jinan 33
San Diego 33
Hebei 31
Rome 31
Tianjin 31
Carate Brianza 30
Falls Church 28
Nürnberg 28
Brussels 27
Chicago 27
Los Angeles 27
Melzo 26
Pune 26
Zhengzhou 26
London 25
Kunming 24
Mountain View 22
Ningbo 20
Shangdi 20
Dallas 19
Codroipo 17
Tokyo 17
Bergamo 16
Norwalk 16
Phoenix 16
Leawood 14
Taizhou 14
Edmonton 13
Hefei 13
Pasir Mas 12
Shinjuku 12
Washington 12
Huizen 11
Kiev 11
Lissone 11
Paris 11
San Mateo 11
Florence 10
Fuzhou 10
Sesto San Giovanni 10
Sacramento 9
Bologna 8
Changchun 8
Trieste 8
Auburn Hills 7
Haikou 7
Lappeenranta 7
Philadelphia 7
Redmond 7
Romola 7
Seoul 7
Ankara 6
Chongqing 6
Detroit 6
Elmhurst 6
Frederick 6
Monza 6
Munich 6
Piemonte 6
Totale 14.410
Nome #
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 416
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 321
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 305
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 300
Age-related changes in the function and structure of the peripheral sensory pathway in mice 297
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 292
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 284
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 248
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 239
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 236
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 233
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 218
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 211
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 205
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 197
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 192
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 186
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 185
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 185
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 182
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 181
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 176
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 174
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 172
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 169
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 169
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 169
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 168
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 163
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 163
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 162
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 162
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 159
Lipoplatin tm: a less neurotoxic formulation of cisplatin 159
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 158
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 158
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 157
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 155
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 154
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 154
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 152
Focus on the role of Glutamate in the pathology of the peripheral nervous system 151
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 151
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 149
Lack of sterol regulatory element binding factor-1c imposes glial fatty acid utilization leading to peripheral neuropathy 148
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 147
Docetaxel-induced peripheral neuropathy: Protective effects of dihydroprogesterone and progesterone in an experimental model 145
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 144
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 143
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 141
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 140
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 139
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 139
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 136
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 136
Regression of diabetic complications by islet transplantation in the rat 135
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 134
The role of glutamate in diabetic and in chemotherapy induced peripheral neuropathies and its regulation by glutamate carboxypeptidase II. 134
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 132
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 132
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 132
Multimodal experimental approach to the study of human neurological diseases 130
MSCs effect on Dark Agouti rats affected by chronic EAE 129
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 129
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 128
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 128
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 128
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 128
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 128
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 128
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 128
Imunohystochemical characterization of the distribution of glutamate receptors, “high affinity” membrane bound glutamate transporters and of Glutamate Carboxipeptidase II (GCPII) in in vitro cultures of embryonic dorsal root ganglia. 127
Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity 127
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 126
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice 126
Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy 125
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 125
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 125
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 125
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 125
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 125
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 122
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 121
electrophysiological, behavioural and morphological characterization of oxaliplatin-induced painful peripheral neuropathy in mice 121
Effect of proteasome inhibition on the central and peripheral nervous system 121
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 121
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 119
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 118
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 117
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 116
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 115
Glutamate Carboxypeptidase II inhibition in several rat models of chemotherapy-induced peripheral neurotoxicity 115
Expression, distribution and glutamate uptake activity of excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 115
Characterization of Glutamate Transporters in Peripheral Nervous System. 114
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat 111
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 111
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 110
Glutamate Carboxypeptidase II (GCPII, NAALADASE) inhibition protects against Cisplatin-induced peripheral neurotoxicity in a rat model. 110
Calcium-related neurotoxicity of oxaliplatin: Understanding the mechanisms to drive therapy 107
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 106
Totale 15.904
Categoria #
all - tutte 72.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.924 0 0 0 0 0 389 525 217 284 252 217 40
2020/20212.636 139 113 297 295 208 184 278 204 242 222 162 292
2021/20221.700 102 165 121 158 144 195 68 91 70 127 113 346
2022/20233.212 383 842 338 278 213 518 56 164 280 34 65 41
2023/20242.685 97 77 104 115 326 670 465 128 172 67 49 415
2024/20252.954 399 851 610 322 550 222 0 0 0 0 0 0
Totale 21.317